Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder that affects approximately 10-15% of the global population. It is characterized by chronic abdominal pain, bloating, and altered bowel habits, significantly impacting patients' quality of life.
Diagnosis primarily relies on the Rome IV criteria, which includes recurrent abdominal pain for at least one day per week in the last three months, associated with two or more of the following: related to defecation, change in stool frequency, or change in stool form.
Management of IBS requires a multi-faceted approach. Lifestyle modifications such as regular exercise, adequate sleep, and stress management are beneficial. Dietary modifications including low-FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) diet have shown promising results. Pharmacologic treatments include antispasmodics, probiotics, and antidepressants.
Cognitive-behavioral therapy (CBT) and hypnotherapy are useful adjuncts in managing IBS, particularly in patients with associated psychological comorbidities.
Effective management of IBS requires a comprehensive, patient-centered approach. Further research is needed to refine these strategies and improve patient outcomes.
1.
Why are so many young adults getting cancer?
2.
Breast cancer-related fatigue: The benefits of adapted physical activity
3.
EHA: European Hematology Association
4.
PSMA PET Beats MRI in Prostate Cancer Staging Study
5.
According to research, hospitals can save money and help cancer patients by implementing a basic intervention.
1.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
2.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
3.
Neutrophil Profiling and AI Rewrites Cancer Diagnosis
4.
The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care
5.
Engineering the Future of Oncology with CAR- Natural Killer Cell Design & Therapeutics
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part XIII
2.
Innovations in Hematology
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
4.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation